First Time Loading...

Clinuvel Pharmaceuticals Ltd
ASX:CUV

Watchlist Manager
Clinuvel Pharmaceuticals Ltd Logo
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Watchlist
Price: 15.9 AUD 5.02% Market Closed
Updated: Jun 1, 2024

Clinuvel Pharmaceuticals Ltd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Clinuvel Pharmaceuticals Ltd
PP&E Net Peer Comparison

Comparables:
IMM
MSB
CSL
TLX
PYC

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Clinuvel Pharmaceuticals Ltd
ASX:CUV
PP&E Net
AU$7.9m
CAGR 3-Years
39%
CAGR 5-Years
89%
CAGR 10-Years
51%
Immutep Ltd
ASX:IMM
PP&E Net
AU$795.5k
CAGR 3-Years
34%
CAGR 5-Years
84%
CAGR 10-Years
0%
Mesoblast Ltd
ASX:MSB
PP&E Net
$5.5m
CAGR 3-Years
-19%
CAGR 5-Years
45%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
PP&E Net
$9.6B
CAGR 3-Years
12%
CAGR 5-Years
20%
CAGR 10-Years
19%
Telix Pharmaceuticals Ltd
ASX:TLX
PP&E Net
AU$30.5m
CAGR 3-Years
85%
CAGR 5-Years
167%
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
PP&E Net
AU$1.2m
CAGR 3-Years
4%
CAGR 5-Years
48%
CAGR 10-Years
15%

See Also

What is Clinuvel Pharmaceuticals Ltd's PP&E Net?
PP&E Net
7.9m AUD

Based on the financial report for Dec 31, 2023, Clinuvel Pharmaceuticals Ltd's PP&E Net amounts to 7.9m AUD.

What is Clinuvel Pharmaceuticals Ltd's PP&E Net growth rate?
PP&E Net CAGR 10Y
51%

Over the last year, the PP&E Net growth was 212%. The average annual PP&E Net growth rates for Clinuvel Pharmaceuticals Ltd have been 39% over the past three years , 89% over the past five years , and 51% over the past ten years .